Lukatch Heath — SEC Form 4 filings
SEC reporting owner CIK 1596385. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-31 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 9,000 shares, $627,500 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 5,000 shares @ $71.50 ($357,500) in Vaxcyte, Inc., filed 2024-02-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | Director | 6 | — | 2 legs · 9,000 sh · $627,500 | 14 |
Form 4 filings — Lukatch Heath
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 2,265 @ $0 · Grant/award (A): 11,389 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 3,041 @ $0 · Grant/award (A): 15,372 (derivative) @ $0 | EDGAR |
| 2025-04-10 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 6,000 @ $16 · Option exercise (M): 1,000 @ $21.49 · Option exercise (M): 6,000 (derivative) @ $0 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Vaxcyte, Inc. (PCVX) | Grant/award (A): 1,550 @ $0 · Grant/award (A): 7,250 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 5,000 @ $16 · Sale (S): 5,000 @ $71.50 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | Vaxcyte, Inc. (PCVX) | Option exercise (M): 4,000 @ $16 · Sale (S): 4,000 @ $67.50 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1596385 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →